Max International Medical Symposium Series Part IV

ENDOGENOUS GLUTATHIONE

RESEARCH AND DEVELOPMENT OF RIBOCEINE™  
~ AN ORAL GLUTATHIONE PRECURSOR

Starts September 1st, 2022
9:00 am EST

Presented by
Dr. Scott Nagasawa


In the world’s current health environment, this timely and relevant presentation includes comprehensive information including:

  • Scientific Overview of Glutathione
  • Glutathione’s Biochemistry
  • Glutathione Benefits: Antioxidant, Detoxifier, Immune System Enhancer
  • Glutathione Depletion:
    • Causes
    • Diseases of Oxidative Stress & Glutathione Depletion
    • Endogenous versus Exogenous Glutathione
  • Endogenous Glutathione Precursors
    • Research & Development of RiboCeine™ (D-Ribose + L-Cysteine) 
    • Research Comparison of RiboCeine to NAC
    • Independent Clinical Research

Dr. Scott Nagasawa, PHARM D. 
Executive Director of Product Research,
Max International
CTO and Co-Founder of Cellgevity
Clinical Instructor of Pharmacy Practice, University of Southern California (USC)
Adjunct Assistant Professor of Pharmacy Practice at USC

Bobbi Horne
VP Corporate Wellness & Healthcare Professional Division,
Max International
Clinical Research Professional
SmartDNA Practitioner
Cardiovascular Consultant


Join Us!

Max Medical Symposium Series Part IV

For more information, please visit RiboseCysteine.com

Share This Post: